NO20001871L - Nye 3,6-hemiacetaler fra klassen 9a-azalider - Google Patents

Nye 3,6-hemiacetaler fra klassen 9a-azalider

Info

Publication number
NO20001871L
NO20001871L NO20001871A NO20001871A NO20001871L NO 20001871 L NO20001871 L NO 20001871L NO 20001871 A NO20001871 A NO 20001871A NO 20001871 A NO20001871 A NO 20001871A NO 20001871 L NO20001871 L NO 20001871L
Authority
NO
Norway
Prior art keywords
group
individually
represents hydrogen
carbon atoms
individually represents
Prior art date
Application number
NO20001871A
Other languages
English (en)
Norwegian (no)
Other versions
NO20001871D0 (no
Inventor
Gabrijela Kobrehel
Gorjana Lazarevski
Mladen Vinkovic
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HR970551A external-priority patent/HRP970551B1/xx
Priority claimed from HR980497A external-priority patent/HRP980497B1/xx
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Publication of NO20001871D0 publication Critical patent/NO20001871D0/no
Publication of NO20001871L publication Critical patent/NO20001871L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20001871A 1997-10-16 2000-04-11 Nye 3,6-hemiacetaler fra klassen 9a-azalider NO20001871L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HR970551A HRP970551B1 (en) 1997-10-16 1997-10-16 Novel o-methyl azythromycin derivatives
HR980497A HRP980497B1 (en) 1998-09-10 1998-09-10 NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES
PCT/HR1998/000005 WO1999020639A2 (fr) 1997-10-16 1998-10-13 NOUVEAUX 3,6-HEMICETALS APPARTENANT A LA CLASSE DES 9a-AZALIDES

Publications (2)

Publication Number Publication Date
NO20001871D0 NO20001871D0 (no) 2000-04-11
NO20001871L true NO20001871L (no) 2000-04-17

Family

ID=26317108

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001871A NO20001871L (no) 1997-10-16 2000-04-11 Nye 3,6-hemiacetaler fra klassen 9a-azalider

Country Status (25)

Country Link
US (1) US6369035B1 (fr)
EP (2) EP1437359B1 (fr)
JP (1) JP2001520234A (fr)
KR (1) KR100554549B1 (fr)
CN (1) CN1281615C (fr)
AR (1) AR018014A1 (fr)
AT (2) ATE267835T1 (fr)
AU (1) AU755315B2 (fr)
BG (1) BG64650B1 (fr)
BR (1) BR9812808A (fr)
CA (1) CA2306963C (fr)
DE (2) DE69824201T2 (fr)
DK (2) DK1437359T3 (fr)
EE (1) EE04681B1 (fr)
ES (2) ES2279242T3 (fr)
HU (1) HUP0004085A3 (fr)
IL (2) IL135648A0 (fr)
NO (1) NO20001871L (fr)
NZ (1) NZ503897A (fr)
PL (1) PL191087B1 (fr)
PT (2) PT1437359E (fr)
RU (1) RU2220148C2 (fr)
SI (2) SI1036083T1 (fr)
SK (1) SK285914B6 (fr)
WO (1) WO1999020639A2 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE200100245A (et) * 1998-11-03 2002-10-15 Pfizer Products Inc. Uued makroliidsed antibiootikumid
KR100361397B1 (ko) * 2000-03-15 2002-11-23 한미약품공업 주식회사 에리스로마이신 에이 9-오-트로필옥심 유도체를 이용한클라리스로마이신의 제조방법
US20040005641A1 (en) 2002-02-15 2004-01-08 Michael Burnet Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
AU2003211113B2 (en) 2002-02-15 2007-08-09 Merckle Gmbh Antibiotic conjugates
EP1483277A4 (fr) 2002-02-15 2007-10-03 Merckle Gmbh Conjugues de composes biologiquement actifs, procedes de preparation et d'utilisation, et formulation et applications pharmaceutiques
HRP20020779A2 (en) 2002-09-27 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. NEW 3-DECLADINOSYL DERIVATIVES OF 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICIN A 9a, 11-CYCLIC CARBAMATES
ITMI20022292A1 (it) * 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
WO2004106353A1 (fr) * 2003-05-30 2004-12-09 Pliva - Istrazivacki Institut D.O.O. Procede d'alkylation selective de derives de macrolides et d'azalides
US7435805B2 (en) 2003-05-30 2008-10-14 Glaxpsmithkline Istrazivacki O-alkyl macrolide and azalide derivatives and regioselective process for their preparation
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US7402568B2 (en) * 2004-09-29 2008-07-22 Enanta Pharmaceuticals, Inc. Bicyclic 9a-azalide derivatives
US7271155B2 (en) * 2005-01-07 2007-09-18 Enanta Pharmaceuticals, Inc. 9A, 11-2C-bicyclic 9a-azalide derivatives
WO2008106224A1 (fr) * 2007-02-28 2008-09-04 Rib-X Pharmaceuticals, Inc. Composés macrolides et procédés de fabrication et d'utilisation de ceux-ci
US9145436B2 (en) 2010-10-10 2015-09-29 Michael W. Burnet Anti-inflammatory macrolides
EP2831083A4 (fr) * 2012-03-27 2016-03-09 Michael W Burnet Macrolides anti-inflammatoires
JP7184520B2 (ja) * 2018-01-22 2022-12-06 旭化成株式会社 トランス型脂環式カーボネートの製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
MX12213A (es) * 1987-07-09 1993-05-01 Pfizer Metodo de preparacion de dihidrato de azitromicina cristalino
HU198913B (en) * 1987-09-03 1989-12-28 Pliva Pharm & Chem Works Process for producing 10-dihydro-10-deoxo-11-aza-erythronolide a-derivatives and pharmaceutical compositions containing them as active components
WO1989002271A1 (fr) * 1987-09-10 1989-03-23 Pfizer Azithromycine et derives utilises comme agents anti-protozoaires
SI9011409A (en) * 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
JP2880338B2 (ja) * 1991-10-25 1999-04-05 株式会社森組 圧搾気体による被移送物の圧送方式
FR2691464B1 (fr) * 1992-05-21 1995-06-02 Roussel Uclaf Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments.
AU7961498A (en) * 1997-06-26 1999-01-19 Merck & Co., Inc. 9a-azalides, compositions containing such compounds and methods of treatment

Also Published As

Publication number Publication date
CA2306963C (fr) 2007-05-01
SI1437359T1 (sl) 2007-06-30
EP1036083B9 (fr) 2005-01-12
BR9812808A (pt) 2005-04-12
EE200000226A (et) 2001-06-15
ATE348836T1 (de) 2007-01-15
RU2220148C2 (ru) 2003-12-27
AR018014A1 (es) 2001-10-31
CN1280585A (zh) 2001-01-17
HK1032785A1 (en) 2001-08-03
NO20001871D0 (no) 2000-04-11
EP1437359B1 (fr) 2006-12-20
DE69824201D1 (de) 2004-07-01
WO1999020639A2 (fr) 1999-04-29
EP1437359A2 (fr) 2004-07-14
PT1437359E (pt) 2007-04-30
SI1036083T1 (en) 2004-10-31
CN1281615C (zh) 2006-10-25
EE04681B1 (et) 2006-08-15
NZ503897A (en) 2002-10-25
KR100554549B1 (ko) 2006-03-03
ATE267835T1 (de) 2004-06-15
PL340372A1 (en) 2001-01-29
KR20010031160A (ko) 2001-04-16
DE69824201T2 (de) 2005-09-22
CA2306963A1 (fr) 1999-04-29
PT1036083E (pt) 2004-10-29
US6369035B1 (en) 2002-04-09
DK1437359T3 (da) 2007-04-30
AU755315B2 (en) 2002-12-12
HUP0004085A3 (en) 2003-05-28
DK1036083T3 (da) 2004-09-27
IL135648A (en) 2007-03-08
ES2222610T3 (es) 2005-02-01
EP1437359A3 (fr) 2005-03-30
ES2279242T3 (es) 2007-08-16
PL191087B1 (pl) 2006-03-31
WO1999020639A3 (fr) 1999-07-08
AU9362298A (en) 1999-05-10
JP2001520234A (ja) 2001-10-30
IL135648A0 (en) 2001-05-20
SK5522000A3 (en) 2000-11-07
DE69836697D1 (de) 2007-02-01
BG104445A (en) 2001-02-28
DK1036083T5 (da) 2005-04-04
SK285914B6 (sk) 2007-11-02
BG64650B1 (bg) 2005-10-31
EP1036083A2 (fr) 2000-09-20
DE69836697T2 (de) 2007-10-04
HUP0004085A2 (hu) 2001-04-28
EP1036083B1 (fr) 2004-05-26

Similar Documents

Publication Publication Date Title
NO20026253D0 (no) Organiske forbindelser
YU47099B (sh) Postupak za dobijanje makrolidnih jedinjenja
BG104445A (en) NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES
EA200200774A1 (ru) Новые соединения, обладающие гиполипидемической, гипохолестеринемической активностью, способ их получения и содержащие их композиции
ES431059A1 (es) Procedimiento para la preparacion de nuevos n-(metoximetil - furilmetil)-6, 7-benzomorfanos y -morfinanos.
KR930016436A (ko) 4, 13-디옥사바이사이클로[8.2.1]트리데세논유도체와 그의 제조방법, 그의 제조를 위한 중간체 및 이화합물이 함유된 약학조성물
MX9600503A (es) 10-aminoalifatil-dibenz(b,f)oxepinas anti-neurodegenerativamente activas.
KR840003646A (ko) 20-아미노틸로신 유도체의 제조방법
IE43847L (en) N-substituted phenylpiperidine derivatives.
DE3869075D1 (de) 2-piperazinyl-2-oxo-aethylensubstituierte flavonoid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammenstellungen.
NO960441L (no) Benzopyraner og farmasöytiske forbindelser inneholdende dem
DE60043293D1 (de) VAKUOLAR-TYP (H+)-ATPase-HEMMENDE VERBINDUNGEN, ZUSAMMENSETZUNGEN UND DEREN VERWENDUNGEN
SE8405514D0 (sv) Furyl-derivat av 16-substituerade prostaglandiner och forfarande for deras framstellning
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
ES8405017A1 (es) Procedimiento para la preparacion de compuestos heterociclicos.
NO20006350L (no) Derivater av 3-(2-okso-[1,3']bipyrrolidinyl-3-ylidenmetyl)- cephemer
ES2142771A1 (es) Nuevos derivados de la 6-(4-penilbutoxi) hexilamina y procedimiento para la obtencion de salmeterol.
NO970766D0 (no) Fremgangsmåte for fremstilling av taxol og derivater derav
EA200101209A1 (ru) Новые производные бензола, способ их получения и фармацевтические композиции, содержащие их
KR870003107A (ko) 키산틴 유도체의 제조방법
EA199900156A1 (ru) Новые производные эритромицина, способ их получения и их применение в качестве медикаментов
DE3788149D1 (de) Prostazyklin-(PGI2)-Analoge.
CO4810380A1 (es) Derivados de eritromicina
IL66384A (en) Indolin-2-one(3,4-dihydroquinol-2-one or quinol-2-one)-oxyalkylsulphimines and salts thereof,their preparation and pharmaceutical compositions containing them
ES8506011A1 (es) Procedimiento para la obtencion de un derivado de tetrahidrobenzotiazol

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application